Last $0.47 USD
Change Today +0.02 / 4.44%
Volume 20.4K
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

guided therapeutics inc (GTHP) Snapshot

Open
$0.45
Previous Close
$0.45
Day High
$0.47
Day Low
$0.45
52 Week High
05/17/13 - $0.98
52 Week Low
04/8/14 - $0.40
Market Cap
33.7M
Average Volume 10 Days
61.2K
EPS TTM
$-0.15
Shares Outstanding
71.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for GUIDED THERAPEUTICS INC (GTHP)

Related News

No related news articles were found.

guided therapeutics inc (GTHP) Related Businessweek News

No Related Businessweek News Found

guided therapeutics inc (GTHP) Details

Guided Therapeutics, Inc., a medical technology company, focuses on developing medical devices. The company primarily develops LuViva, a non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-care by scanning the cervix with light, then analyzing the light reflected or emanating from the cervix. It is also developing a non-invasive test for the early detection of esophageal cancer using the technology platform. The company was formerly known as SpectRx, Inc. and changed its name to Guided Therapeutics, Inc. in February 2008. Guided Therapeutics, Inc. was founded in 1992 and is based in Norcross, Georgia.

30 Employees
Last Reported Date: 03/26/14
Founded in 1992

guided therapeutics inc (GTHP) Top Compensated Officers

Senior Vice President of Engineering and Secr...
Total Annual Compensation: $197.0K
Chief Scientific Officer and Executive Direct...
Total Annual Compensation: $243.0K
Compensation as of Fiscal Year 2013.

guided therapeutics inc (GTHP) Key Developments

Guided Therapeutics, Inc Announces Unaudited Consolidated Earnings Results for Fourth Quarter and Full Year Ended Dec. 31, 2013

Guided Therapeutics Inc. announced unaudited consolidated earnings results for fourth quarter and full year ended Dec. 31, 2013. For the quarter, the company reported revenue contract and grant revenue of $346,000, operating loss of $1,350,000, net loss attributable to common stockholders of $4,217,000 or $0.06 per basic and diluted share compared to the revenue contract and grant revenue of $1,012,000, operating loss of $1,167,000, net loss attributable to common stockholders of $1,187,000 or $0.02 per basic and diluted share for the same quarter a year ago. The increased loss reported for the quarter ended December 31, 2013 was primarily related to the reduction in contract and grants income, as well as non-cash deemed dividends on preferred stock and warrant valuation combined of approximately $2.7 million. For the year, the company reported revenue contract and grant revenue of $820,000, operating loss of $6,606,000, net loss attributable to common stockholders of $10,390,000 or $0.16 per basic and diluted share compared to the revenue contract and grant revenue of $3,338,000, operating loss of $4,281,000, net loss attributable to common stockholders of $4,353,000 or $0.08 per basic and diluted share for the previous year. For the year, the increased loss was primarily related to the reduction in contract and grants income of approximately $2.5 million and non-cash, deemed dividends on preferred stock and warrant valuation combined of approximately $3.8 million.

Guided Therapeutics, Inc, Q4 2013 Earnings Call, Mar 27, 2014

Guided Therapeutics, Inc, Q4 2013 Earnings Call, Mar 27, 2014

Guided Therapeutics, Inc to Report Q4, 2013 Results on Mar 26, 2014

Guided Therapeutics, Inc announced that they will report Q4, 2013 results at 5:00 PM, Eastern Standard Time on Mar 26, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
GTHP:US $0.47 USD +0.02

GTHP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for GTHP.
View Industry Companies
 

Industry Analysis

GTHP

Industry Average

Valuation GTHP Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 27.1x
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales 26.9x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact GUIDED THERAPEUTICS INC, please visit www.guidedinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.